For the quarter ending 2026-03-31, NMRA has $153,877K in assets. $83,197K in debts. $147,072K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Restricted cash | - | - | 0 | 0 |
| Short-term marketable securities | - | - | 42,454 | 93,065 |
| Cash and cash equivalents | 147,072 | 182,530 | 129,071 | 124,523 |
| Prepaid expenses and other current assets | 6,362 | 8,007 | 5,557 | 5,321 |
| Total current assets | 153,434 | 190,537 | 177,082 | 222,909 |
| Property and equipment, net | 32 | 40 | 80 | 87 |
| Operating lease right-of-use assets | 358 | 417 | 474 | 531 |
| Other assets | 53 | 53 | 197 | 298 |
| Total assets | 153,877 | 191,047 | 177,833 | 223,825 |
| Accounts payable | 5,057 | 3,379 | 549 | 644 |
| Accrued liabilities | 24,767 | 28,788 | 24,982 | 20,253 |
| Early exercise liability, current portion | - | - | 55 | 88 |
| Operating lease liabilities, current portion | 291 | 284 | 256 | 171 |
| Total current liabilities | 30,115 | 32,451 | 25,842 | 21,156 |
| Long term debt, net | 52,963 | 54,532 | 19,563 | 19,451 |
| Operating lease liabilities, noncurrent | 119 | 193 | 267 | 339 |
| Early exercise liability, net of current portion | - | - | 0 | 0 |
| Total liabilities | 83,197 | 87,176 | 45,672 | 40,946 |
| Common stock | 18 | 17 | 16 | 16 |
| Additional paid-in capital | 1,308,269 | 1,288,003 | 1,256,835 | 1,250,822 |
| Accumulated other comprehensive income | - | - | 9 | -15 |
| Accumulated deficit | -1,237,607 | -1,184,149 | -1,124,699 | -1,067,944 |
| Total stockholders' equity | 70,680 | 103,871 | 132,161 | 182,879 |
| Total liabilities and stockholders' equity | 153,877 | 191,047 | 177,833 | 223,825 |
Neumora Therapeutics, Inc. (NMRA)
Neumora Therapeutics, Inc. (NMRA)